Historial de carrera de Claire J. Lockey
Antiguos cargos conocidos de Claire J. Lockey.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TRICIDA, INC. | Corporate Officer/Principal | 12/01/2016 | 01/11/2019 |
| RELYPSA INC | Consejero General | 06/07/2011 | 01/11/2015 |
| Corporate Officer/Principal | 27/04/2010 | 06/07/2011 | |
| FIBROGEN, INC. | Consejero General | 01/07/2003 | 01/01/2010 |
| Synergia LLC | Corporate Officer/Principal | 01/01/1985 | 01/01/1995 |
| Gore Hybrid Technologies, Inc. | Corporate Officer/Principal | - | - |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - | - |
| Layton BioScience, Inc. | Corporate Officer/Principal | - | - |
| TITAN PHARMACEUTICALS, INC. | Consejero General | - | - |
Formación de Claire J. Lockey.
| Boston University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 10 |
Operativa
| Corporate Officer/Principal | 6 |
| General Counsel | 3 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| TITAN PHARMACEUTICALS, INC. | Health Technology |
| TRICIDA, INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
| Layton BioScience, Inc. | |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
| Synergia LLC | |
| Gore Hybrid Technologies, Inc. |
- Bolsa de valores
- Insiders
- Claire J. Lockey
- Experiencia